您的位置: 首页 > 农业专利 > 详情页

SILYLATED BIOMOLECULE-BASED HYDROGEL FOR CULTURING CARDIOMYOCYTES AND STEM CELLS, AND USE OF THE HYDROGEL THEREOF FOR TREATING HEART FAILURE
专利权人:
Pierre Weiss;Jerome Guicheux;Eva Mathieu;Patricia Lemarchand
发明人:
Pierre Weiss,Eva Mathieu,Jerome Guicheux,Patricia Lemarchand
申请号:
US15949509
公开号:
US20180221493A1
申请日:
2018.04.10
申请国别(地区):
US
年份:
2018
代理人:
摘要:
The present invention relates to the use of an hydrogel comprising silylated biomolecule for the three-dimensional culture of cardiomyocytes or stem cells which are able to differentiate into cardiomyocytes, and to an aqueous composition comprising i) cardiomyocytes or stem cells which are able to differentiate into cardiomyocytes, and ii) a hydrogel comprising silylated biomolecule, for use for treating heart failure, in particular heart failure following myocardial infarction.
来源网站:
中国工程科技知识中心
来源网址:
http://www.ckcest.cn/home/

意 见 箱

匿名:登录

个人用户登录

找回密码

第三方账号登录

忘记密码

个人用户注册

必须为有效邮箱
6~16位数字与字母组合
6~16位数字与字母组合
请输入正确的手机号码

信息补充